Evidence map›Paper›PMID 33281484›Full record

ArticleFood technology and biotechnology2020

Evaluation of Nanostructured Lipid Carriers Produced with Interesterified Buriti Oil.

Lívia Viana de Castro Reis, Karina Magna Leão, Paula Speranza, Ana Paula Badan Ribeiro, Gabriela Alves Macedo, Juliana Alves Macedo

Open access · diamondAbstract read
In one paragraph

Article in Food technology and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lívia Viana de Castro ReisFaculty of Food Engineering, Department of Food and Nutrition, State University of Campinas, Monteiro Lobato St. 80, Campinas, SP 13083-970, Brazil.ORCID https://orcid.org/0000-0003-3819-8393
Karina Magna LeãoFaculty of Food Engineering, Department of Food and Nutrition, State University of Campinas, Monteiro Lobato St. 80, Campinas, SP 13083-970, Brazil.ORCID https://orcid.org/0000-0003-0750-8432
Paula SperanzaFaculty of Food Engineering, Department of Food and Nutrition, State University of Campinas, Monteiro Lobato St. 80, Campinas, SP 13083-970, Brazil.ORCID https://orcid.org/0000-0003-4403-3720
Ana Paula Badan RibeiroFaculty of Food Engineering, Department of Food Technology, State University of Campinas, Monteiro Lobato St. 80, Campinas, SP 13083-970, Brazil.ORCID https://orcid.org/0000-0002-6532-1265
Gabriela Alves MacedoFaculty of Food Engineering, Department of Food and Nutrition, State University of Campinas, Monteiro Lobato St. 80, Campinas, SP 13083-970, Brazil.ORCID https://orcid.org/0000-0001-5255-2243
Juliana Alves MacedoFaculty of Food Engineering, Department of Food and Nutrition, State University of Campinas, Monteiro Lobato St. 80, Campinas, SP 13083-970, Brazil.ORCID https://orcid.org/0000-0001-7504-8111
Universidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RESEARCH

backgroundExtracted from the pulp of an Amazonian fruit, buriti oil is rich in micronutrients with antioxidant properties and high biological value. The few studies available indicate that this oil could be used in a wide range of applications; however, there are no studies that work on the improvement in the characteristics of this oil for commercial application. The enzymatic interesterification is one of the tools available to improve the properties of oils and fats and our recent studies have demonstrated that the lipase could specifically act on buriti oil to produce structured lipids rich in oleic acid, while preserving most of the minor compounds present in this oil. Still looking for ways to expand the applicability of this raw oil, in this work, we are interested in studying the behaviour of this structured oil in nanostructured lipid carriers (NLCs). EXPERIMENTAL APPROACH: The NLCs were produced with interesterified buriti oil and the stability, droplet size, electrical charge, microstructure, polymorphism and antioxidant activity of the samples were evaluated by ORAC and FRAP methods. RESULTS AND

conclusionsThe results showed that the interesterification formed more unsaturated triacylglycerols (TAGs), and NLCs prepared with interesterified buriti oil had smaller droplets than NLCs with crude buriti oil. Particles remained stable throughout the storage period and NLCs exhibited complex polymorphism with the presence of three crystalline forms. The oxygen radical absorbance capacity (ORAC) value was approx. 23% higher in nanolipid carries with structured lipids than in the nanolipid carriers with crude buriti oil, and the ferric reducing antioxidant power (FRAP) value 16% higher, demonstrating the influence of interesterification on the antioxidant activity of nanocarriers. Thus, NLCs prepared with interesterified buriti oil had small droplets, high stability and antioxidant capacity, and have a potential for nutritional and biological applications. NOVELTY AND SCIENTIFIC CONTRIBUTION: This research showed that interesterification positively influenced the physicochemical properties of NLCs, producing the oil rich in oleic acid, high stability and antioxidant capacity. Therefore, it may be interesting to use these nanocarriers to obtain efficient carrier systems for future applications.

Indexed as

antioxidant activityburiti oildroplet sizeenzymatic interesterificationnanocarrierstructured lipids

Identifiers

PMID33281484
PMCPMC7709454
OpenAlexW3082309741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.